Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Atrial Fibrillation Patients With Intermediate Stroke Risk”

3 trials

Showing 3 of 3 results

Testing effectiveness (Phase 2)Study completedNCT00240643
What this trial is testing

Use Of SB424323 With Aspirin In Non-Valvular Atrial Fibrillation In Patients At A Low Or Intermediate Risk For Stroke

Who this might be right for
Fibrillation, AtrialAtrial Fibrillation
GlaxoSmithKline 640
Post-approval studies (Phase 4)Study completedNCT04437654
What this trial is testing

The Efficacy and Safety of Non-vItamiN K antaGonist oraL Anticoagulants for intermEdiate Stroke Risk in Patients With Atrial Fibrillation (SINGLE-AF)

Who this might be right for
Atrial Fibrillation Patients With Intermediate Stroke Risk
Yonsei University 1,803
Post-approval studies (Phase 4)Looking for participantsNCT04642430
What this trial is testing

COmparison of Bleeding Risk Between Rivaroxaban and Apixaban in Patients With Atrial Fibrillation

Who this might be right for
Atrial Fibrillation
Ottawa Hospital Research Institute 3,018

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation